Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results

Rhea-AI Summary

Boston Scientific (NYSE: BSX) has announced two upcoming investor events. First, the company will participate in the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025, in San Francisco. CEO Mike Mahoney will present at 5:15 p.m. PT, joined by CFO Dan Brennan and CMO Dr. Kenneth Stein for a Q&A session.

Additionally, BSX will host its fourth quarter 2024 earnings call on February 5, 2025, at 8:00 a.m. ET. Financial results will be released prior to the call. Both events will be accessible via webcast on the company's investor relations website, with replays available approximately one hour after each event.

MARLBOROUGH, Mass., Jan. 2, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 43^rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, in San Francisco. Mike Mahoney, chairman and chief executive officer, will present at approximately 5:15 p.m. PT / 8:15 p.m. ET. Mahoney will be joined by Dan Brennan, executive vice president and chief financial officer, and Kenneth Stein, M.D., senior vice president and chief medical officer, in a question-and-answer session with the host analyst.

Additionally, the company will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2024, on Wednesday, February 5, 2025, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney and Dan Brennan. The company will issue a news release announcing financial results for the fourth quarter on February 5 prior to the conference call.

A live webcast and replay for each event will be accessible at htts://investors.bostonscientific.com. The replays will be available approximately one hour following the completion of each event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.  

CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com

Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-the-jp-morgan-healthcare-conference-and-conference-call-discussing-fourth-quarter-2024-results-302340448.html

SOURCE Boston Scientific Corporation

FAQ

When will Boston Scientific (BSX) release Q4 2024 earnings?

Boston Scientific will release its Q4 2024 earnings on February 5, 2025, before the market opens, followed by a conference call at 8:00 a.m. ET.

When is Boston Scientific's (BSX) presentation at the 2025 J.P. Morgan Healthcare Conference?

Boston Scientific will present at the J.P. Morgan Healthcare Conference on January 13, 2025, at 5:15 p.m. PT / 8:15 p.m. ET.

Who will represent Boston Scientific (BSX) at the 2025 J.P. Morgan Healthcare Conference?

CEO Mike Mahoney will present, joined by CFO Dan Brennan and CMO Dr. Kenneth Stein for the Q&A session.

Where can investors watch Boston Scientific's (BSX) Q4 2024 earnings call?

Investors can access the webcast and replay through Boston Scientific's investor relations website at investors.bostonscientific.com.